Russell Investments Group
STOK icon

Russell Investments Group’s Stoke Therapeutics STOK Stock Holding History

Russell Investments Group’s Portfolio STOK Stock Details STOK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$480K Buy
14,681
+11,059
+305% +$355K ﹤0.01% 2804
2026
Q1 		$118K Buy
3,622
+5
+0.1% +$164 ﹤0.01% 3038
2025
Q4 		$115K Sell
3,617
-214
-6% -$6.43K ﹤0.01% 3013
2025
Q3 		$90K Sell
3,831
-11,919
-76% -$204K ﹤0.01% 3064
2025
Q2 		$179K Sell
15,750
-369
-2% -$3.5K ﹤0.01% 2680
2025
Q1 		$107K Buy
+16,119
New +$150K ﹤0.01% 2736
2024
Q3 		– Sell
-1,527
Closed -$20.6K – 3793
2024
Q2 		$20.6K Buy
+1,527
New +$20.6K ﹤0.01% 2933
2023
Q3 		– Sell
-1,382
Closed -$14.7K – 3621
2023
Q2 		$14.7K Hold
1,382
– – ﹤0.01% 2897
2023
Q1 		$11.5K Hold
1,382
– – ﹤0.01% 2865
2022
Q4 		$12.8K Hold
1,382
– – ﹤0.01% 2834
2022
Q3 		$17K Sell
1,382
-788
-36% -$12.6K ﹤0.01% 2823
2022
Q2 		$28K Buy
+2,170
New +$33K ﹤0.01% 2773
2022
Q1 		– Sell
-13,313
Closed -$319K – 2919
2021
Q4 		$319K Buy
+13,313
New +$318K ﹤0.01% 2588

Other funds holding STOK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Russell Investments Group's STOK Position: Q2 2026 in Review

Russell Investments Group increased its Stoke Therapeutics (STOK) stake by 305% in Q2 2026, buying an estimated $355K and bringing the position to 14,681 shares worth $480K. The position accounts for ﹤0.01% of the portfolio, ranked #2804.

Russell Investments Group first reported a position in STOK in Q4 2021 and has held it in 13 quarters since. 197 funds tracked by Wall St. Rank hold STOK as of Q2 2026.

  • Russell Investments Group held 14,681 shares of Stoke Therapeutics worth $480K as of Q2 2026.
  • Russell Investments Group bought 11,059 Stoke Therapeutics shares in Q2 2026, an estimated $355K.
  • Stoke Therapeutics made up ﹤0.01% of Russell Investments Group's portfolio in Q2 2026, its #2804 holding.
  • Russell Investments Group first reported a position in Stoke Therapeutics in Q4 2021 and has held it in 13 quarters since.
  • 197 funds tracked by Wall St. Rank held Stoke Therapeutics as of Q2 2026.

Based on Russell Investments Group's 13F filing for Q2 2026, filed 6 Aug 2026.